drugset / Trial / NCT02259985

Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects

NCT02259985 ↗

Phase 1 Completed 15 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

food interaction, pharmacokinetics, safety and tolerability

Timeline

Start
1998-03
Primary completion
1998-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Itasetron Small molecule 1 mg Oral

Indications

No indication recorded.